2022
DOI: 10.1016/j.apsb.2022.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
26
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(27 citation statements)
references
References 134 publications
0
26
0
Order By: Relevance
“…Currently, delivery strategies of CRISPR-Cas9 have been composed of two broad categories: viral and nonviral vectors. Since carcinogenesis, insertional mutagenesis, and immunogenicity of viral vectors limits its clinical application, nonviral vectors are growing an alternative strategy 22 , 23 , 24 , 25 , 26 , 27 , 28 . Several nanomaterials-based platforms have been developed to encapsulate Cas9/single-guide RNA (sgRNA) complexes into nanoparticles for delivery of CRISPR, including polymeric nanoparticles, metal–organic frameworks (MOFs), cationic liposomes, gold nanoparticles, and other nanomaterials 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 .…”
Section: Introductionmentioning
confidence: 99%
“…Currently, delivery strategies of CRISPR-Cas9 have been composed of two broad categories: viral and nonviral vectors. Since carcinogenesis, insertional mutagenesis, and immunogenicity of viral vectors limits its clinical application, nonviral vectors are growing an alternative strategy 22 , 23 , 24 , 25 , 26 , 27 , 28 . Several nanomaterials-based platforms have been developed to encapsulate Cas9/single-guide RNA (sgRNA) complexes into nanoparticles for delivery of CRISPR, including polymeric nanoparticles, metal–organic frameworks (MOFs), cationic liposomes, gold nanoparticles, and other nanomaterials 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 .…”
Section: Introductionmentioning
confidence: 99%
“…Tu et al found that both miR-10a and miR-10b can inhibit the expression of key factors in the brain-derived neurotrophic factor ( BDNF ) and the TGF-β signaling pathways, thereby inhibiting the follicular granule cell proliferation and induction of granulosa cell apoptosis [ 40 ]. Wei et al found that miR-10b could target BDNF and inhibit the activity of goat ovarian granulosa cells by inhibiting the expression of BDNF [ 41 ]. However, due to the limited research on the functions of miRNAs in the hypothalamus, the deep functions of the miRNAs screened in this study need to be further studied.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, as artemisnin and medicinal plants have been widely applied in clinic for years, their safety, biocomparability and in vivo dynamics are guaranteed. All the traits make ADNVs a promising therapy or drug carriers for treating tumors or other related illness [56,57].…”
Section: Discussionmentioning
confidence: 99%